|
MedPanel Report Solicits Expert Opinion On The Future Of Stem Cell Research
CAMBRIDGE, MA -- JUNE 15 2001 --In the recent months, stem cell research has become the subject of intense debate. Though the current administration has endorsed limited funding for stem cell research, the battle continues. At the same time doctors and scientists are still discovering the potential for this revolutionary technology.
MedPanel, Inc., announces the publication of MedPanel TrendCast: Stem Cell Therapeutics, a new report that offers first-hand knowledge and opinions on the future of this potentially revolutionary technology.
MedPanel TrendCast: Stem Cell Therapeutics is the result of an online discussion that progressed over a two-week period in May 2001. The discussion participants included 11 physicians who are specialists in cardiology, ophthalmology, dermatology, and orthopedics--areas where tissue engineering has tremendous potential, and in some cases, has already resulted in marketed products. The discussion was structured to elicit the panel's views of the application of emerging stem cell technologies to a variety of diseases, including macular degeneration, corneal diseases, cardiovascular disease, congestive heart failure, cardiac valvular disease, long QT syndrome, some dyslipidemias, hypertrophic cardiomyopathy, osteoarthritis, bone fractures, traumatic neurological injury of the spinal cord or brain, burns, and other conditions resulting in excessive skin loss. The following areas were evaluated:
*The use of fetal versus adult stem cells.
*Obstacles to development given the current political climate surrounding stem cell research.
*Hurdles to the widespread use of such products once they reach the market.
*The impact of stem cell technologies on solid organ transplantation.
About MedPanel
MedPanel provides online qualitative and quantitative primary research, thought leader access, targeted marketing methodologies, and in-depth medical market trend analysis for the pharmaceutical, biotechnology and medical device industries. MedPanel's competitive edge results from enrollment of exclusively contracted top tier physicians and proprietary technology. These services provide companies with an economical and rapid method of obtaining valued opinions and comprehensive research.
Contact: Erin Sheehan 617-661-8080 x29
www.MedPanel.com